NBTX
#2028
Nanobiotix S.A. - ADSs
39.1 5 USD
-0.02%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.30%
Variazione Mensile
+5.24%
Variazione di 6 mesi
+85.19%
Variazione Annuale
+629.05%
Chiusura Precedente
40.0 7
Open
39.1 5
Minimo
39.1 5
High
39.1 5
Volume
4
Financials
- Market Capitalization 1.9 B
- Employee 97
- Founded 2003
- CEO Laurent Levy
- Website www.nanobiotix.com
- Headquarter France
- FIGI BBG00Y9D2SW8
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2012 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.41 USD | -2.03% | -3.49% | +17.71% | +107.02% | 1.94 B USD | ||
| 2014 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 39.51 USD | +2.46% | +5.36% | +33.71% | +107.95% | 1.92 B USD | ||
| 2043 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 21.98 USD | -4.60% | -6.43% | +18.24% | +94.51% | 1.86 B USD | ||
| 2044 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.15 USD | -2.63% | -4.41% | +28.36% | +94.94% | 1.85 B USD |